Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines.

Link BK, Brooks J, Wright K, Pan X, Voelker M, Chrischilles E.

Leuk Lymphoma. 2011 Jun;52(6):994-1002. doi: 10.3109/10428194.2011.557167. Epub 2011 Feb 21.

2.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
3.

Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.

Keating GM.

Drugs. 2010 Jul 30;70(11):1445-76. doi: 10.2165/11201110-000000000-00000. Review.

PMID:
20614951
4.

[Prognostic factors and treatment of diffuse large cell B-cell lymphoma].

Riihijärvi S, Leppä S.

Duodecim. 2014;130(21):2181-9. Review. Finnish.

PMID:
25582012
5.

Anthracycline-containing regimens for treatment of follicular lymphoma in adults.

Itchaki G, Gafter-Gvili A, Lahav M, Vidal L, Raanani P, Shpilberg O, Paul M.

Cochrane Database Syst Rev. 2013 Jul 7;(7):CD008909. doi: 10.1002/14651858.CD008909.pub2. Review.

PMID:
23832787
6.

Promising Novel Agents for Aggressive B-Cell Lymphoma.

Younes A.

Hematol Oncol Clin North Am. 2016 Dec;30(6):1229-1237. doi: 10.1016/j.hoc.2016.07.007. Review.

PMID:
27888877
7.

Nanotherapeutics with anthracyclines: methods of determination and quantification of anthracyclines in biological samples.

Koziolova E, Janouskova O, Chytil P, Studenovsky M, Kostka L, Etrych T.

Physiol Res. 2015;64 Suppl 1:S1-10. Review.

Supplemental Content

Support Center